Genentech ends $2b cancer cell therapy pact with Adaptive
FierceBiotech - 18-Aug-2025Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
Join the club for FREE to access the whole archive and other member benefits.
Biotechnology company developing immune-driven medicine.
Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, we are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated.
Visit website: https://www.adaptivebiotech.com/
adaptive-biotechnologies-corp-
Details last updated 12-Dec-2019
Pharma giant retreats from costly cell therapy deals amid layoffs and R&D cuts
In a few years, we might have enough training data to actually achieve some diagnostic results